Alveolar macrophages (AMs) derived from embryonic precursors seed the lung before birth and self-maintain locally throughout adulthood, but are regenerated by bone marrow (BM) under stress conditions. However, the regulation of AM development and maintenance remains poorly understood. Here, we show that histone deacetylase 3 (HDAC3) is a key epigenetic factor required for AM embryonic development, postnatal homeostasis, maturation, and regeneration from BM. Loss of HDAC3 in early embryonic development affects AM development starting at E14.5, while loss of HDAC3 after birth affects AM homeostasis and maturation. Single-cell RNA sequencing analyses reveal four distinct AM sub-clusters and a dysregulated cluster-specific pathway in the HDAC3-deficient AMs. Moreover, HDAC3-deficient AMs exhibit severe mitochondrial oxidative dysfunction and deteriorative cell death. Mechanistically, HDAC3 directly binds to Pparg enhancers, and HDAC3 deficiency impairs Pparg expression and its signaling pathway. Our findings identify HDAC3 as a key epigenetic regulator of lung AM development and homeostasis.
Alveolar macrophages (AMs), the resident macrophages in lung alveoli, are important for the maintenance of homeostasis in the airways and are involved in the development of a variety of pulmonary diseases1. Recent lineage-tracing studies have demonstrated that tissue-resident macrophages (TRMs) originate from embryonic yolk sac (YS) erythro-myeloid progenitors (EMPs) and can self-renew in most adult tissues at steady state without contribution from bone marrow (BM) hematopoietic stem cells (HSCs)2,3,4. YS EMP cells differentiate into premacrophages (pMacs) that colonize all embryonic organs as TRMs starting at embryonic day 9.5 (E9.5)5. The YS EMPs also enter the fetal liver (FL) starting from E12.5, where they expand and differentiate into pMacs and/or monocytes that travel to local tissues through the blood and eventually become tissue-specific TRMs4. Fetal monocytes begin to accumulate in the developing lung at E14.5 and then differentiate into immature AMs (preAMs) expressing F4/80intCD11bint, which postnatally mature into AMs expressing CD11chiSiglec-FhiCD11blo,4,6,7. Like the majority of other TRMs, AMs self-maintain locally at steady state throughout adult life4,8. Under stressed conditions, AMs are either self-maintained by local proliferation or completely replaced by bone marrow-derived cells in a challenge-dependent manner9,10.
A few genes have been identified as requirements for AM development and homeostasis. Granulocyte macrophage colony-stimulating factor (GM-CSF) was shown to be essential for the perinatal differentiation of fetal monocytes into preAMs and for the full maturation of AMs postnatally7. Transforming growth factor-β (TGF-β) is also crucial for the embryonic differentiation of fetal monocytes into preAMs, their postnatal maturation, as well as the homeostasis of adult AMs11. Both GM-CSF and TGF-β signaling pathways induce the expression of PPAR-γ, a signature transcription factor essential for the development of AMs7,11. Macrophage identity and homeostasis require the precise regulation of gene expression that is governed by different epigenetic mechanisms, such as DNA methylation, histone modification, and chromatin structure12. However, very little is known about the epigenetic factors that regulate AM development from EMPs and fetal monocytes, as well as its postnatal homeostasis.
Histone deacetylases (HDACs) are enzymes that regulate gene expression by modifying chromatin structure through the removal of acetyl groups from target histones or through direct deacetylation of non-histone proteins. HDACs exhibit limited substrate specificity and rely on transcription factors with specific DNA-binding and/or chromatin-binding activities in order to target specific genes13. Class I HDACs (HDAC1, 2, 3, 8) can assemble into multi-component co-repressor13 or co-activator14 complexes that regulate the transcription of a broad array of genes which fundamentally impact cellular physiology, organism development, and disease pathogenesis15,16,17,18. Several pan HDAC inhibitors (HDACi) have been approved by the FDA for anti-tumor therapy19. More recently, HDACi was suggested for use in the treatment of asthma and other inflammatory lung diseases20,21. HDAC3, belonging to the class I HDAC family, is required for the macrophage inflammatory gene expression program22 and serves as an epigenetic brake in macrophage alternative activation23. However, it remains unknown whether HDAC3 is involved in the ontogeny and homeostasis of AMs.
In this study, we aim to investigate the role of HDAC3 in the embryonic development and postnatal maintenance of AMs. Using mice with TRM or AM lineage-specific or time-specific HDAC3 deletion and the bone marrow chimeric mouse model, we demonstrate that HDAC3 deficiency leads to severe impairment of AM ontogeny, maintenance, maturation, and regeneration. Single-cell RNA sequencing analyses reveal that AMs have four unique sub-populations and that a lack of HDAC3 gives rise to AM subset-specific pathway dysregulation. Moreover, loss of HDAC3 results in dysregulated mitochondrial oxidative phosphorylation and cell survival. Mechanistically, HDAC3 directly binds to Pparg gene enhancers and regulates PPAR-γ signaling during AM development. Our findings uncover HDAC3 as a key epigenetic factor in the regulation of lung AM embryonic development and maintenance after birth.
HDAC3 is required for the embryonic development of AMs
Before birth, F4/80hiCD11bint pMac-derived fetal macrophages5 and F4/80intCD11bhi FL monocytes sequentially colonize the developing lung around E12.5 and E14.5, respectively8. Fetal monocytes further differentiate into F4/80intCD11bint preAMs, which become CD11chiSiglec-FhiCD11blo AMs during the first week of life. To investigate the role of HDAC3 in AMs, we first examined the expression pattern of HDAC3 in the lung fetal macrophages and preAMs during embryonic development, as well as AMs at a young age and adulthood, using qRT-PCR. As shown in Fig. 1a, HDAC3 was expressed in lung fetal macrophages at E14.5 and in preAMs at E16.5 and E18.5, but its expression was dramatically increased in AMs from the young (P14, ~20-fold) and adult (~40-fold) mice. These results suggest that HDAC3 is potentially involved in AM embryonic development and maintenance after birth.
To determine whether HDAC3 regulates embryonic development of AMs, we generated Csf1riCreHdac3fl/fl conditional knockout (cKO) mice, in which HDAC3 is deficient in the Csf1r-expressing myeloid cells, including TRMs and monocytes24,25. Both HDAC3 mRNA and protein were efficiently depleted (>80%) in preAMs from the HDAC3cKO newborns as determined by qRT-PCR and flow cytometry, respectively (Fig. 1b, c). We next examined the fetal macrophages, preAMs, and fetal monocytes in the lung from Csf1riCreHdac3fl/fl cKO mouse embryos and wild type (WT) littermates between E12.5 and right after birth (P0). There was no significant alteration in the frequencies of F4/80hiCD11blo fetal macrophages and F4/80loCD11bhi monocytes in the lung between cKO and WT embryos at E12.5 (Fig. 1d, e, gates shown in Supplementary Fig. 1a). However, a modest but significant reduction in the frequency of fetal macrophages was observed in HDAC3cKO embryos at E14.5 and E16.5, followed by a gradual diminish afterwards. On the other hand, the frequency of F4/80intCD11bint preAM cells that emerged at E16.5 in the fetal lung was dramatically decreased in HDAC3cKO compared to WT littermates starting at E16.5 until birth. In contrast, fetal monocytes showed compensatorily increased distribution in the absence of HDAC3 starting at E14.5. Immunofluorescence staining of lung tissue sections at E18.5 further confirmed that the number of lung preAMs was significantly reduced in the HDAC3cKO mice (Fig. 1f). Collectively, these results suggest that HDAC3 is indispensable for the development of YS pMac-derived lung macrophages and FL monocyte-derived preAMs during embryogenesis.
Next, we investigated whether HDAC3 deficiency blocks EMP development and differentiation into pMacs and FL monocytes in the YS and FL, respectively. Interestingly, within the CD45+Lin– (CD45-expressing; lineage negative) population, the frequencies of CD117hiF4/80– EMPs, CD117–F4/80– pMacs, and CD117–F4/80+ macrophages in the YS remained unaltered in HDAC3cKO embryos compared to the WT at E9.5, E10.5, and E12.5 (Fig. 1g, h, gates shown in Supplementary Fig. 1b), suggesting that HDAC3 is dispensable for EMPs and their further differentiation into pMacs and YS macrophages. Furthermore, we observed comparable frequencies of EMPs in the FL between the HDAC3cKO and WT embryos at E10.5 and E12.5, suggesting that the loss of HDAC3 also does not affect EMP seeding in the FL (Fig. 1g, h). In addition, the frequency of CD64loCD11bhiLy6chi FL monocytes remained unaltered during the embryonic stage (E14.5-E18.5) in the HDAC3cKO mice (Fig. 1i, j, gates shown in Supplementary Fig. 1c). HDAC3 deletion in FL monocytes, which was confirmed by qRT-PCR and flow cytometry (Supplementary Fig. 2a, b), does not disrupt their differentiation into TRMs in other organs, such as the brain, spleen, kidney, and pancreas (Supplementary Fig. 3a, b, gates shown in Supplementary Fig. 1a). Overall, HDAC3 deficiency does not affect EMPs, their ability to differentiate into pMacs in the YS, or FL monocyte development, but it may play key roles in pMac-derived macrophages and FL monocyte-derived preAMs in the lung.
HDAC3 is essential for the maintenance of AMs after birth
We next examined the AMs from the Csf1riCreHdac3fl/fl cKO adult mice. As expected, the frequency of lung AMs (CD11chiSiglec-Fhi) was markedly decreased in the HDAC3cKO adult mice (Fig. 2a, gates shown in Supplementary Fig. 1d). This reduction was further confirmed by immunofluorescence staining of frozen tissue sections (Fig. 2b). After birth, preAMs quickly downregulate their CD11b expression and become mature AMs7. As shown in Fig. 2c, the remaining AMs in the HDAC3-deficient mice were found to highly express CD11b. This suggests that maintenance of mature AMs in the adult mice is very likely dependent on HDAC3. However, given that Csf1r.Cre-induced gene deletion occurs in the embryonic stage, the AM defects observed in the Csf1riCreHdac3fl/fl cKO adult mice may be due to embryonic developmental dysregulation rather than a maintenance abnormality after birth.
To address this question, we next generated mice with a constitutive HDAC3 deficiency in AMs postnatally by crossing Hdac3fl/fl mice with CD11cCre transgenic mice, given that CD11c is highly expressed in AMs after birth7. We found that the frequency and number of AMs were dramatically reduced in CD11cCreHdac3fl/flcKO mice compared to their WT counterparts (Fig. 2d), and that CD11b was highly expressed on AMs from CD11cCreHdac3fl/flcKO mice (Fig. 2e). We further generated inducible HDAC3-deficient mice by crossing Hdac3fl/fl mice with ubiquitin C promoter-driven, tamoxifen-inducible Cre (UbcCreER) transgenic mice, in which tamoxifen (TAM) timely induces HDAC3 deletion. UbcCreERHdac3fl/fl mice (6–8 weeks old) were treated with TAM for 5 consecutive days, then lung AMs were analyzed 1 week and 3–5 weeks after TAM treatment. Successful HDAC3 deletion in the targeted cells was confirmed by qRT-PCR (Supplementary Fig. 4a). Although normal distribution of AMs was observed in UbcCreERHdac3fl/fl mice at 1 week post-TAM treatment (Supplementary Fig. 4b), lack of HDAC3 led to a significant reduction in the frequency and number of lung AMs at 3–5 weeks post-treatment (Fig. 2f). Taken together, these findings suggest that HDAC3 also plays a key role in the maintenance of AM homeostasis, as well as their maturation after birth at steady state.
Regeneration of AMs from the BM depends on HDAC3
AMs self-maintain at steady state independently of circulating precursors9. However, under certain inflammatory conditions or BM transplantation following lethal whole-body irradiation, BM-derived monocytes can repopulate the AM niche9,26. We next sought to determine whether BM-derived AMs are also dependent on HDAC3. To do this, we established a BM chimeric mouse model by co-transferring BM cells from Hdac3fl/fl or Csf1riCreHdac3fl/fl cKO donors (CD45.2+) with competitor BM cells from B6.SJL WT mice (CD45.1+) into the irradiated B6.SJLhetero (CD45.1+CD45.2+) recipient mice (Fig. 3a). As expected, in the chimeric mice, lung AMs were radiosensitive and largely replaced by BM-derived cells from both WT donor and competitor mice (Fig. 3b). However, the BM from HDAC3cKO mice completely failed to reconstitute lung AMs compared to the BM from WT mice. These findings suggest that HDAC3 is not only important for embryonically-derived AMs, but also required for the regeneration of AMs from adult BM under stress conditions.
HDAC3 regulates AM subset-specific gene expression profile
Recent single-cell studies have shown that heart and liver TRMs are heterogeneous populations at steady state27,28. To characterize whether lung AMs are also heterogeneous, we sorted CD11chiSiglec-Fhi AMs from Hdac3fl/fl WT adult mice and performed single-cell RNA-sequencing (scRNA-seq) using the 10× Genomics platform. More than 2000 cells were analyzed and T-distributed stochastic neighbor embedding (t-SNE) dimensionality reduction analysis identified 4 major AM clusters (Fig. 4a). Each AM sub-cluster has a unique gene expression pattern (Fig. 4b) with their signature genes (Fig. 4c). Of the AM clusters, cluster 1 was the most abundant and expressed macrophage-associated genes, such as Abcg1, Mrc1, and Mpeg1. Cluster 2 expressed genes such as Birc5, Top2a, Rrm2, and Stmn1, which are involved in the cell cycle and mitosis. Cluster 3 had relatively higher expression of antigen-presentation genes, such as H2-Eb1, H2-Ab1, H2-Aa, and Cd74. Cluster 4 was enriched in many genes associated with immune response, such as Tnf, Il1a, Cxcl1, Cxcl2, and Cxcl3. The cluster-specific gene expression pattern suggests that each AM cell subset may have a distinct role in AM maintenance and function.
In order to determine whether HDAC3 is required for the maintenance of a specific lung AM cell subset, we next performed scRNA-seq on the sorted AM cells from Cd11cCreHdac3fl/flcKO mice and compared the AM clusters between HDAC3cKO and WT mice. Although the composition of clusters 1 and 2 remained almost unaltered in the KO, the frequency of cluster 3 was increased from 3.3% to 4.9%, while the frequency of cluster 4 was reduced from 4.0% to 2.4% in the absence of HDAC3 (Fig. 4d, e). This suggests that the loss of HDAC3 may affect the maintenance of AM subsets in a cluster-specific manner. In addition, we also observed certain cluster-specific transcriptomic changes between WT and cKO mice (Supplementary Fig. 5). Ingenuity pathway analysis (IPA) revealed that each AM cluster in the cKO mice exhibited distinct dysregulated pathways compared to that in their WT counterpart (Fig. 4f). In cluster 1, the key disordered pathways included phagosome maturation, unfolded protein response, mitochondria dysfunction, and BAG2 signaling pathways, which are associated with macrophage phagocytosis, polarization, survival, and stress responses. In cluster 2, the pathways related to cell cycle control were less enriched in the cKO cells. In cluster 3, several immune-responsive pathways were upregulated in the cKO cells, including E1F2 signaling, Th1/Th2 pathways, and dendritic cell maturation. In cluster 4, the pathways involved in cytokine signaling (i.e., IL-6 and IL-10 signaling) and acute phase response signaling were less enriched in the cKO cells, whereas Toll-like receptor signaling, neuroinflammation signaling pathway, and communication between innate and adaptive immune cells, were strongly enriched in the cKO cells. These data reveal that HDAC3 deficiency results in cluster-specific pathway dysregulation in AMs at steady state, which may lead to distinct function disorders in each AM cluster.
Interestingly, when we analyzed transcriptomes of AM populations without clustering, we identified a total of 186 differentially expressed genes, including 59 upregulated genes and 127 downregulated genes in the HDAC3-deficient AMs compared to their WT counterparts (Supplementary Fig. 6a). IPA of these differentially expressed genes showed that several canonical pathways related to inflammation and immune responses were significantly inhibited in the HDAC3cKO AMs (Supplementary Fig. 6b). Moreover, the signaling pathways related to macrophage survival and apoptosis were also remarkably impaired, including TREM1 signaling29,30, NF-kB pathway31,32, and STAT3 pathway33,34. qRT-PCR analysis further confirmed the downregulation of the genes associated with these three pathways, such as Flt1, Mapk3, Map3k1, Tlr2, Fcgr2b, Tgfb1, and Tgfbr1 (Supplementary Fig. 6c). These data suggest that the inhibition of TREM1, NF-kB, and STAT3 signaling pathways might reduce cell survival of HDAC3cKO AMs, leading to the decreased total number of AM cells in the absence of HDAC3 as we observed at steady-state maintenance (Fig. 2d). On the other hand, scRNA-seq also revealed that PPAR-γ was remarkably reduced in HDAC3-deficient AMs (Supplementary Fig. 6a), suggesting that HDAC3 might control AM homeostasis through regulation of PPAR-γ.
HDAC3 controls mitochondria function and survival of preAMs
To further obtain mechanistic insights into the embryonic deficiency of AMs in the absence of HDAC3, we first performed bulk RNA-seq analysis of lung preAMs from cKO and WT at E18.5. Based on the principal component analysis (PCA) of their transcriptomes, the molecular signatures showed a clear difference in preAMs between cKO and WT (Fig. 5a). A total of 9074 differentially expressed genes (P < 0.05) were identified in the preAMs between HDAC3cKO and WT, including 4612 downregulated and 4462 upregulated genes (Fig. 5b, Supplementary Data 1). Gene Ontology (GO) analysis further identified the altered biological pathways in the HDAC3cKO preAMs, including multiple metabolic pathways, the electron transport chain, cell proliferation, and cell death (Fig. 5c, Supplementary Data 2). Most of the identified pathways are consistent with previous studies in other cell types with HDAC3 deletion14,35,36.
Furthermore, gene set enrichment analysis (GSEA) identified some gene sets that were either depleted (normalized enrichment score, NES < 0, false discovery rate, FDR < 0.05) (Supplementary Fig. 7a, b) or enriched in HDAC3cKO phenotype (NES > 0, FDR < 0.05) (Supplementary Fig. 8a, b). Notably, the genes involved in oxidative phosphorylation were significantly downregulated in HDAC3-deficient preAMs (Fig. 5d). Many subunits of protein complexes I-V of the electron transport chain, the key component of the oxidative phosphorylation process, were diminished in the absence of HDAC3 (Fig. 5e, f). In addition, we observed a significant decrease in Mitotracker Orange fluorescence-labeled AMs from cKO, which reflects the reduced mitochondria membrane potential and indicates impaired mitochondria function in HDAC3-deficient lung preAMs (Fig. 5g). Moreover, GSEA demonstrated that the absence of HDAC3 led to a strong enrichment of genes involved in apoptosis signaling (Fig. 5h–j). Enhanced apoptosis of preAMs at E18.5 was further confirmed by flow cytometry (Fig. 5k). These results suggest that HDAC3 regulates preAM mitochondrial oxidative function and cell death, which may be related to defective embryonic AM development in HDAC3 cKO mice.
HDAC3 deficiency causes impaired PPAR-γ signaling in preAMs
We next sought to identify the direct downstream targets of HDAC3 for AM development. To achieve this, we performed HDAC3 ChIP-Seq analysis of lung AMs from the WT mice, which was further integrated with our bulk RNA-seq data. We found 2502 genes shared in both datasets that may be primary targets of HDAC3 transcriptional regulation (Fig. 6a). IPA analysis of these differentially expressed genes revealed that PPAR signaling was one of the canonical pathways potentially targeted by HDAC3 (Fig. 6b). Indeed, the repression of Pparg mRNA expression was correlated with the loss of HDAC3 in HDAC3-deficient preAMs (Fig. 6c). ChIP-seq analysis also showed that HDAC3 can directly bind to Pparg enhancers that are located in the upstream (within −30 kilobases (kb)) or intronic (+49 kb) regions from the transcription start sites in lung AMs from the WT mice, but not in the HDAC3cKO mice (Fig. 6d, Supplementary Data 3). The binding of HDAC3 to the Pparg enhancers was further confirmed by ChIP-qPCR using MH-S cells, a mouse AM cell line (Fig. 6e). Moreover, the GSEA of bulk RNA-seq data revealed that the absence of HDAC3 led to a significantly weaker enrichment of genes involved in PPAR-γ signaling compared to WT (Fig. 6f, g). Lack of HDAC3 resulted in the downregulation of PPAR-γ target genes, including Ppargc1b, Acsl1, Cidec, Fabp4, Mgst3, and Nr1h3, which was further confirmed by qRT-PCR (Fig. 6h). Collectively, these results indicate that HDAC3 directly targets PPAR-γ in AMs, and that loss of HDAC3 fundamentally abrogates the PPAR-γ signaling pathway during AM development.
PPAR-γ regulates mitochondria function and survival of preAMs
A prior study has shown impaired development of fetal lung preAMs in Vav1-Cre-induced, PPAR-γ-deficient mice at E18.57, indicating that prenatal PPAR-γ is required for AM ontogeny. Using Csf1riCrePpargfl/flcKO mice, we further found a modest reduction of F4/80hiCD11bint YS pMac-derived lung fetal macrophages at E14.5 and a drastic loss of F4/80intCD11bint fetal liver monocyte-derived preAMs at E17.5 from Csf1riCrePpargfl/flcKO mice (Fig. 7a), which were consistent with the phenotype observed in HDAC3cKO mice (Fig. 1d, e). As expected, CD11chiSiglec-Fhi AMs were essentially eliminated in the Csf1riCrePpargfl/flcKO adult mice (Fig. 7a), which was consistent with the previous results using Vav1Cre- and Cd11cCrePpargfl/flcKO mice7. Moreover, PPAR-γ gene expression was detected in the lung fetal macrophages at E14.5, which was gradually upregulated in preAMs at E16.5 and E18.5, and maintained at high levels in the AMs from young and adult mice (Fig. 7b). Interestingly, PPAR-γ mRNA was not expressed in the TRMs of the kidney, liver, brain, and heart (Supplementary Fig. 9), suggesting that HDAC3-PPAR-γ axis is specifically required for the development of lung AMs, but not for TRMs in other tissues.
We next revisited a recently-published microarray dataset7 and analyzed gene expression profiles of lung preAMs from Ppargfl/fl WT and Cd11cCrePpargfl/flcKO mice at day 2 after birth. As expected, the PPAR-γ signaling pathway in preAMs was severely impaired in the absence of PPAR-γ, which was consistent with our observations in Csf1riCreHdac3fl/flcKO mice (Fig. 7c). Interestingly, oxidative phosphorylation-related genes, which were severely diminished in HDAC3cKO mice, were robustly reduced in PPAR-γ-deficient mice (Fig. 7d–f). ChIP-qPCR analysis using MH-S cells further showed an enrichment of PPAR-γ binding sites in the promoter regions (within 3 kb of the transcription start sites) of oxidative phosphorylation-related genes, including Atp5l, Cox5a, Cox5b, Cox6a1, Ndufa4, Sdhb, Uqcrfs1, and Uqcrq, all of which were downregulated in the absence of PPAR-γ (Fig. 7e, f), suggesting a possible direct impact of PPAR-γ on mitochondria function-related genes in AMs (Fig. 7g). Moreover, the apoptosis-associated genes were highly enriched in PPAR-γ-deficient mice compared to their WT counterparts, which was also consistent with our observations in HDAC3cKO mice (Fig. 7h–j). These data suggest that the PPAR-γ signaling pathway serves as a key pathway that contributes to the dysregulation of mitochondrial oxidative function and cell survival in the HDAC3-deficient AMs. Taken together, our study demonstrates that the HDAC3-PPAR-γ axis is indispensable for normal mitochondrial oxidative function and cell survival during AM development (Fig. 7k).
The concept of TRMs has been refreshed in the past few years. Recent lineage-tracing studies have revealed that adult mouse TRMs are derived from embryonic YS EMP-derived macrophages and FL monocytes rather than from bone marrow-derived precursors, and they are self-maintained at steady state after birth2,24,37. Although a few genes (e.g., Csf2, Pparg, and Tgfb) have been identified as requirements for AM development, little information is known about the epigenetic regulators that instruct the development and maintenance of AMs. HDAC3, belonging to the class I HDAC family, plays a critical role in many biological processes, including circadian rhythm17, intestinal homeostasis38, and tissue thermogenesis14. Here, we demonstrate that HDAC3 is required for embryonic development and postnatal maintenance of lung AMs at steady state. In addition, HDAC3 controls AM regeneration from BM progenitors after lethal whole-body irradiation. Our data further indicate that HDAC3 is dispensable for development of TRMs in the brain, spleen, kidney, and pancreas, suggesting that HDAC3 regulates TRM ontogeny in an organ-specific manner.
As the resident macrophages in lung alveoli, AMs are long lived with proliferative self-renewal capability, and control the maintenance of airway homeostasis through their capacity of clearing surfactant and cell debris at steady state1,39. During respiratory infection or inflammation, AMs also function as antigen-presenting cells by transporting exogenous antigens to lung-draining lymph nodes and releasing a wide array of cytokines and chemokines to reprogram both innate and adaptive immune responses40,41. However, it remains unclear whether multifunctional roles of AMs are derived from AM heterogeneity at the individual cell level. Recent advances in single-cell technology have provided a powerful tool to study tissue and cell heterogeneity28,42,43,44. To address if the AMs are heterogenous at steady state and if HDAC3 regulates AM heterogeneity and subset function, we performed scRNA-seq of mature AMs in the adult mice from WT and CD11cCre.HDAC3 KO mice. We found that the murine lung tissues contain four transcriptionally-distinct AM cell subsets. The most abundant cluster (cluster 1) accounted for over 85% of the total lung AMs and expressed high levels of genes related to lipid metabolism, including Abcg145 and Ltc4s46. Thus, this abundant AM cluster may be specialized for pulmonary surfactant lipid clearance. It has been shown that the adult AM network is maintained throughout life by a slow local proliferation of lung AMs rather than from BM precursors8. Interestingly, one of the minor AM clusters (cluster 2, 6%) was characterized by higher expression of cell cycle-related genes, and may represent proliferating AM cells that slowly renew the AM network, which has yet to be further tested. Another minor AM cluster (cluster 3, 3%) was enriched in many antigen-presentation-related genes and may represent the AM subpopulation that possesses antigen-presenting function47. Furthermore, the most minor AM cluster (cluster 4, 4%) highly expressed a variety of genes involved in immune responses and may serve as the major source of AMs for secreting pro-inflammatory cytokines and chemokines during inflammatory conditions. Together, our data suggest that individual AM subpopulations might be specialized for unique functions to regulate lung homeostasis and antipathogen immunity.
Interestingly, HDAC3 deficiency resulted in unproportionable changes in the number of AM sub-cluster cells, indicating a cluster-dependent effect of HDAC3 on AM homeostasis. Moreover, the transcriptomic changes and their associated pathway dysregulation induced by HDAC3 deletion in AMs also showed a cluster-specific pattern, i.e., mitochondria dysfunction in cluster 1, cell cycle control disorders in cluster 2, antigen-presenting dysfunction in cluster 3, and immune response dysregulation in cluster 4. Notably, the mitochondria dysfunction found in the abundant AM cluster (cluster 1) is consistent with our observations from bulk-RNA seq data showing impaired mitochondrial oxidative function and deteriorative cell death in the absence of HDAC3 during AM development. Given the importance of mitochondria function in immune metabolism and cell survival of macrophages48, we reason that the loss of cluster 1 caused by impaired mitochondria function largely contributes to the reduced number of total AM cells in the HDAC3cKO mice. Moreover, the disorders of cell cycle control and DNA damage response in the proliferating cluster (cluster 2) likely lead to less proliferative capacity of this cluster, which may also partially contribute to the reduced number of HDAC3-deficient AM cells. On the other hand, loss of HDAC3 significantly affected the antigen-presenting function of cluster 3 and the immune-responsive function of cluster 4, suggesting that HDAC3 might crucially control the function of both AM clusters during immune responses. Further studies are needed to assess the role of HDAC3 in the functionality of individual AM subpopulations in the pathogenesis of lung diseases, such as asthma and cancer. Furthermore, it remains to be determined whether fetal immature preAMs have subpopulations and how HDAC3 regulates preAM subsets, if any, during embryonic development. However, given severe developmental defects on preAMs in the absence of HDAC3, we currently could not obtain enough cells from the KO littermates for scRNA-seq analysis. Advanced technology, e.g., mass cytometry, may serve as a promising and powerful tool to address these interesting questions in the future49.
Inhibition of HDACs is emerging as a promising approach to treat various types of malignant diseases, neurodegenerative diseases, inflammatory disorders, and cardiovascular diseases50. Four pan HDACi have been approved by the FDA as anticancer agents for treatment of lymphoma and multiple myeloma, while many other pan HDACi are currently in clinical trials for treatment of lymphoma and solid tumors51. HDACi have also been recently suggested in the treatment of asthma and other inflammatory lung diseases20,21. However, due to common side effects of these pan HDAC inhibitors, developing drugs with high selectivity for individual HDAC has drawn great attention. On the other hand, different subtypes of HDACs appear to play disparate roles in immune defense and disease progression52. Understanding the underlying mechanism by which individual HDACs regulate immune cell development, maintenance, and function will help us to identify potential therapeutic treatments. In the present study, deletion of HDAC3 leads to repressed PPAR-γ expression in fetal immature AMs, as well as adult mature AMs, as confirmed by bulk RNA-seq and scRNA-seq analyses, respectively, suggesting the essential role of the HDAC3-PPAR-γ axis in the development and maintenance of AMs. In addition, our data imply that the HDAC3-PPAR-γ axis controls fetal immature AM development, at least partially through regulation of mitochondria function and cell survival. Interestingly, PPAR-γ binding sites are enriched near the genes associated with oxidative phosphorylation, suggesting that PPAR-γ might directly regulate mitochondrial oxidative function in AMs. On the other hand, given lack of PPAR-γ expression in TRMs from other organs, the HDAC3-PPAR-γ axis seems to be only required for TRM development in a lung-specific manner. It should be noted that a very recent single-cell study revealed an enrichment of PPAR-γhi macrophages in human lung adenocarcinoma lesions that likely promotes an immunosuppressive microenvironment53. Thus, HDAC3i could be promising immunotherapeutic drugs to treat lung cancer patients by targeting the HDAC3-PPAR-γ axis in lung macrophage populations, which needs to be further investigated.
In conclusion, our data have provided evidence that HDAC3 serves as a key epigenetic regulator to control AM development at the embryonic stage, as well as in AM maintenance and regeneration after birth. Accumulated research has indicated that AMs are involved in the development of cancer, autoimmune, and inflammatory diseases in the airway. Thus, our findings may shed light on HDAC3 as a potential therapeutic target for AM-based intervention in cancer and autoimmune diseases.
Hdac3fl/fl mice were provided by Scott W. Hiebert54. C57BL/6 (Strain #000664), B6.SJL (Strain #002014), Cd11cCre (Strain #008068), Csf1riCre (Strain #021024), UbcCreER (Strain #007001), and Ppargfl/fl (Strain #004584) mice were purchased from the Jackson Laboratory (Bar Harbour, ME). To generate myeloid lineage-specific HDAC3 mutant mice, we crossed Hdac3fl/fl and Csf1riCre mice (back to a B6/C57 mouse genetic background for 6 generations). To generate CD11c-expressing, cell-specific HDAC3 mutant mice, we crossed Hdac3fl/fl and Cd11cCre mice. To generate inducible HDAC3 deletion mice, we crossed Hdac3fl/fl and UbcCreER mice. To generate myeloid lineage-specific PPAR-γ-deficient mice, we crossed Ppargfl/fl and Csf1riCre mice. To generate heterozygous mice expressing both CD45.1 and CD45.2, named B6.SJLhetero, we crossed B6.SJL (CD45.1) with C57BL/6 (CD45.2) mice.
Male and female mice from 6–18 weeks of age were used. All experiments included age-matched and sex-matched littermate controls. Embryonic development was estimated considering the day of vaginal plug formation as embryonic age of 0.5 days.
All mice were housed under specific pathogen-free conditions at temperatures of 20–26 °C with 30–70% humidity and a 12-h light/12-h dark cycle at Henry Ford Health System. Experimental animal protocols were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee.
Genotyping of Csf1riCre55, Cd11cCre56, UbcCreER57, and Ppargfl/fl58 mice was performed in adherence to the standard PCR-based procedure. The following primers were used for each mouse strain: Csf1riCre: forward 5′-CTAGGCCACAGAATTGAAAGATCT-3′ and reverse 5′-ATCAGCCACACCAGACACAGAGATC-3′; Cd11cCre: forward 5′-ACTTGGCAGCTGTCTCCAAG-3′ and reverse 5′-GCGAACATCTTCAGGTTCTG-3′; UbcCreER: forward 5′-GACGTCACCCGTTCTGTTG-3′ and reverse 5′-AGGCAAATTTTGGTGTACGG-3′; Ppargfl/fl: 5′-CTAGTGAAGTATACTATACTCTGTGCAGCC-3′ and 5′-GTGTCATAATAAACATGGGAGCATAGAAGC-3′. Hdac3fl/fl mice were genotyped using the following PCR primer pair: 1597B, 5′-GGACACAGTCATGACCCGGTC-3′; 1133T, 5′-CTCTGGCTTCTGCTATGTCAATG-3′. The floxed allele of Hdac3fl/fl mice produced a 504-bp PCR product, whereas the wild type allele resulted in a 464-bp PCR product.
MH-S cells (ATCC, CRL-2019) were cultured with RPMI 1640 with 4.5 g/L D-glucose (Gibco/Thermo Fisher Scientific), 10% FBS, 0.05 mM 2-Mercaptoethanol (Gibco/Thermo Fisher Scientific), and 1% penicillin-streptomycin-amphotericin B at 37 °C in 5% CO2. The cell line was passaged at approximately 80–90% confluence.
Isolation of embryonic and adult cells
Pregnant females were sacrificed by CO2 exposure. Embryos ranging from embryonic days E10.5-E18.5 were removed from the uterus and washed in 4 °C phosphate-buffered saline ([PBS], Invitrogen, Carlsbad, CA). Embryos were exsanguinated through decapitation. Lungs, liver, brain, kidneys, spleen, and pancreas were collected, minced into tiny pieces, and incubated for 30 min in PBS containing 1 mg/ml collagenase D (Roche, Basel, Switzerland), 0.01% DNase I (Worthington Biochemical Corp., Lakewood, NJ), and 3% FBS (Hyclone, San Angelo, TX) at 37 °C. Erythrocytes from all the samples were lysed for 3 min with 0.83% NH4Cl buffer. The cells from the adult tissues were isolated by the same method with some modifications. The adult lungs were harvested, minced, and incubated in PBS containing 1 mg/ml collagenase D (Roche), 0.01% DNase I (Worthington), and 3% FBS (Hyclone) at 37 °C for 45 min. The erythrocytes were lysed as described above. All the cell suspensions were passed through a 70 μm cell strainer (BD Biosciences, San Jose, CA).
Flow cytometry and cell sorting
Single-cell suspensions were centrifuged at 450 × g for 7 min, resuspended in ice-cold staining buffer (1× PBS with 2% FBS), and placed in 96-well round-bottom plates. After incubation with purified anti-FcγRII/III antibody (clone 2.4G2) at 4 °C for 15 min, cells were stained with a mixture of fluorescent surface antibodies at 4 °C for 30 min. The stained samples were either directly analyzed by flow cytometry or fixed with 2% formalin at 4 °C for 20 min prior to storage at 4 °C overnight. The full list of antibodies used can be found in Supplementary Table 1. Flow cytometry was performed with FACSAria™ II or FACSCelesta™ flow cytometer (BD Biosciences). Data were acquired using BD FACSDiva software version 8.0.2 (BD Biosciences) and analyzed using FlowJo 10.5.3 (BD Biosciences).
The CD45+CD11chiSiglec-Fhi lung AMs of adult Hdac3fl/fl and UbcCreERHdac3fl/fl mice were sorted by FACS Aria II flow cytometer. The CD45+F4/80hiCD11bint fetal lung macrophages at E14.5, CD45+F4/80intCD11bintpreAMs at E16.5 and E18.5, CD45+CD11chiSiglec-Fhi adult lung AMs, as well as CD45+F4/80intCD11bhi FL monocytes at E16.5 from Hdac3fl/fl and Csf1riCreHdac3fl/fl mice were also sorted by FACSAria™ II flow cytometer. The purity of the isolated populations was >95%.
Mitochondria function and cell apoptosis assays
The MitoTracker Orange (Invitrogen/Thermo Fisher Scientific) stock solution was prepared according to the manufacturer’s instructions. Briefly, 50 μg of lyophilized MitoTracker Orange dye was dissolved in DMSO to a final concentration of 1 mM and stored at −20 °C in the dark. Cells were incubated with 50 nM MitoTracker Orange in the prewarmed RPMI 1640 medium at 37 °C with 5% CO2 for 15 min, followed by two washes with PBS. The stained cells were analyzed by flow cytometry (Ex 554 nm, Em 576 nm).
Cell apoptosis was measured using the Annexin V Apoptosis Detection Kit (eFuorTM450 or APC, eBioscience/Thermo Fisher Scientific). In brief, freshly-isolated cells were washed once with 1× binding buffer and resuspended in 100 μL of 1× Binding Buffer at 5 × 106/ml. After adding 3 μL of fluorochrome-conjugated Annexin V, the cells were incubated at RT for 13 min. The stained cells were washed once with 1× binding buffer and analyzed by flow cytometry.
Tamoxifen (Sigma Aldrich, St. Louis, MO) was dissolved in corn oil (Sigma Aldrich) containing 10% (vol/vol) ethanol (Thermo Fisher Scientific) and was intraperitoneally administered at 50 mg/kg of mouse weight for five consecutive days.
Bone marrow chimeras
B6.SJLHetero (CD45.1+CD45.2+) mice were lethally irradiated once with 950 rads. Donor BM cells were harvested from age-matched and sex-matched CD45.2+ Hdac3fl/fl and Csf1riCreHdac3fl/fl mice, as well as B6.SJL (CD45.1+) mice. The BM cells from Hdac3fl/fl or Csf1riCreHdac3fl/fl mice were mixed with the cells from B6.SJL mice (at a 4:1 ratio) and then co-transferred to the irradiated B6.SJLHetero recipient mice (10 × 106 mixed cells/mouse). The recipient mice were sacrificed 10 wks after reconstitution.
RNA extraction and quantitative real-time PCR
Total RNA was extracted from TRMs with miRCURY RNA Isolation Kit—Cell and Plant (Exiqon). The RNA was reverse-transcribed to cDNA with High Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster City, CA). Quantitative real-time PCR (qRT-PCR) reactions were prepared using FastStart Universal SYBR Green Master (ROX, Roche) and carried out using QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems). Data were collected using QuantStudio 7 Flex Real-Time PCR System software version 1.2 (Applied Biosystems) and analyzed using Microsoft Excel 2016 (Microsoft, Redmond, Washington). The full list of primers used can be found in Supplementary Table 2. Samples were normalized to GAPDH expression.
A piece of lung or liver freshly isolated from adult mice or embryos at E18.5 was immediately frozen in OCT compound for cryostat sectioning (5 μm per section). The frozen tissue sections were fixed with acetone for 15 min at −20 °C. After rinsing with PBS for 5 min, samples were blocked with anti-FcγRII/III antibody at RT for 15 min followed by staining at 4 °C overnight with PE-labeled anti-Siglec-F (adult lung) or PE-labeled anti-F4/80 (fetal lung) antibody. The samples were then stained with 1 μg/ml DAPI at RT for 1 min and mounted under a coverslip with one drop of IMMU-MOUNT (Thermo Fisher Scientific). Specimens were visualized on an Olympus FSX100 fluorescence microscope (Olympus Scientific Solutions Americas Corp, Waltham, MA) at ×10 magnification. At least 5 independent images were collected from each specimen. Images were collected using FSX-BSW (version 03.02.12) software (Olympus). The cell density of AMs (Siglec-F+) or preAMs/TRMs (F4/80+) was measured based on cell numbers counted in the fields using cellSens Dimensions Imaging Software version 1.15 (Olympus).
Bulk RNA sequencing
To achieve optimal library quality, cDNA synthesis and preamplification for total RNA of the sorted lung preAMs from WT or Csf1riCreHdac3fl/fl cKO embryos at E18.5 were performed using the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech, Mountain View, CA) following the manufacturer’s instructions. Briefly, cDNA was pre-amplified by a thermal cycler (Applied Biosystem) using 12–14 cycles and sheered into 150–400 bp fragments using a Bioruptor Pico sonicator (Diagenode, Denville, NJ). The DNA ends were repaired using End-It™ DNA End-Repair Kit (Epicentre, Charlotte, SC). The end-repaired DNA fragments were ligated to adapters by T4 ligase (New England Bioloabs, Ipswich, MA) after a single A was added at 3′ by Klenow Fragment (3′ → 5′ Exo-) (New England Bioloabs). MinElute Reaction Cleanup Kit (Qiagen, Gaithersburg, MD) was used for DNA cleanup after each step. Illumina P5 and P7 primers with indicated adapters (Supplementary Table 3) were used for final library amplification. The 150–400 bp final product was purified on a 2% E-gel (Thermo Fisher Scientific). Sequencing was performed by the DNA sequencing core facility at University of Michigan using a 50 bp single end read setup on the Illumina Hiseq 4000 platform.
Single-cell RNA sequencing
Single-cell sequencing libraries were generated by an established protocol using the 10× Genomics Chromium Single Cell 3′ Reagent Kit (v2 Chemistry) and Chromium Single Cell Controller59. Briefly, 5000 FACS-sorted cells were loaded into each reaction for gel bead-in-emulsion (GEM) generation and cell barcoding. Reverse transcription of the GEM (GEM-RT) was performed using a Veriti™ 96-Well Fast Thermal Cycler, (Applied Biosystems) at 53 °C for 45 min, 85 °C for 5 min, and a 4 °C hold. cDNA amplification was performed after GEM-RT cleanup with Dynabeads MyOne Silane (Thermo Fisher Scientific) using the same thermocycler (98 °C for 3 min, 98 °C for 15 s, 67 °C for 20 s, 72 °C for 1 min, followed by a 12 cycle repeat at 72 °C for 1 min and a 4 °C hold). Amplified cDNA was cleaned up with SPRIselect Reagent Kit (Beckman Coulter, Brea, CA) that was followed by a library construction procedure, including fragmentation, end repair, adapter ligation, and library amplification. An Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) was used for library quality control. Libraries were sequenced on an Illumina HiSeq4000 using a paired-end flow cell: Read 1, 26 cycles; i7 index, 8 cycles; Read 2, 98 cycles.
Cell pellets from freshly-isolated AMs (1.38 × 106 and 0.77 × 106 cells for WT and cKO, respectively) of adult Hdac3fl/fl WT (n = 13) or Csf1riCreHdac3fl/fl cKO mice (n = 26) were directly frozen at −80 °C. The samples were then submitted to EpiGentek (Farmingdale, NY) for ChIP, library preparation, and sequencing. Briefly, the cells were fixed with 1% formaldehyde and chromatin was isolated using a ChromaFlashTM Chromatin Extraction Kit. Chromatin was sheared using the Episonic2000 Sonicatin System. ChIP was performed using an antibody against HDAC3 (Abcam, #ab7030, polyclonal, 2 µg/500 µl assay buffer) on the chromatin, and input DNA (without immunoprecipitation) was used as background. After adapter linking, the library was size selected (100–300 bp) and PCR amplified. Ten nanomolar of each sample library was provided for next generation sequencing on a HiSeq 4000.
The ChIP assay was performed on 80–90% confluent cultures using an EZ-ChIP kit (Millipore, Burlington, MA, #17-371) and 1 μg of anti-RNA Polymerase II antibody (Millipore, #05-623B, clone CTD4H8, 1 μg/ml), 2 μg of anti-HDAC3 antibody (Abcam, #ab32369, clone Y415, 2 μg/ml), 1 μg of anti-PPAR-γ antibody (Cell Signaling, Danvers, MA, #2443 S, clone 81B8, 1 μg/ml), and 1 μg of rabbit IgG (Abcam, #ab171870, polyclonal, 1 μg/ml) per reaction. DNA-relative enrichment was determined by normalization to an input genomic DNA. All ChIP experiments were obtained from independent chromatin preparations, and all quantitative real-time PCR reactions were performed in duplicates for each sample on each amplicon. Primers for the ChIP-qPCR are listed in Supplementary Table 2.
Bulk RNA-Seq and ChIP-Seq data processing
The RNA-Seq reads were aligned to the mouse GRCm38/mm10 reference genome and expression levels for each sample were quantified and normalized using Biomedical Genomics Workbench 5.0 (Qiagen). Gene ontology (GO) biological process enrichment analysis was performed using DAVID Bioinformatics Resources 6.860. Gene Set Enrichment Analysis (GSEA) was performed using GSEA software 4.0.361,62. Further pathway analysis was performed using the Ingenuity Pathway Analysis ([IPA], Qiagen Bioinformatics, version 42012434). Raw ChIP-seq reads were quality checked using the software FastQC version v0.10.163 and processed using BBDuk (v36.19) and seqtk (v1.2-r94, https://github.com/lh3/seqtk) to trim the adapters and low-quality bases, respectively. The trimmed reads were then aligned to the mouse mm10 genome sequence using Bowtie2 (v2.2.5)64 and only uniquely-matching reads were retained. Mapping results of each ChIP and the input sample were subjected to ChIP-enriched peak calling using the MACS265 (v184.108.40.20660309). Peak annotation was conducted using ChIPseeker (v1.24.0)66.
scRNA-seq data processing
Paired-end read counts for all known murine genes underwent barcode and unique molecular identifier (UMI) deconvolution. They were subsequently aligned to the mm10 reference genome using the 10× Cell RangerTM [v2.1] pipeline67,68. A total of 2000–3000 cells were captured, with 53,000–73,000 mean reads per cell, and 1200–1300 median genes per cell. Datasets were subsequently analyzed using R-3.3.2 package Seurat’s Canonical Correlation Analysis (CCA) workflow to characterize the differences between pooled samples69.
The following quality control metrics were employed. To identify potential doublets, cells expressing uncharacteristically high numbers of genes (>2500) were excluded (double the median number of genes). Low-quality cells were excluded based on a low number of genes detected (<300) or having high mitochondria genetic content (>5.0%). In addition, uninteresting sources of variation within the data were removed. Genes removed include sex-specific genes (Xist and all Y chromosome genes), ribosomal structural proteins as identified by gene ontology term GO:0003735 and the RPG: Ribosomal Protein Gene database70, non-coding rRNAs, Hbb, and genes expressed in <3 cells.
The global-scaling normalization method, LogNormalize, was employed to normalize gene expression measurements of each cell by the total expression, multiplying this by a factor of 10,000, followed by log-transformation. Highly variable genes in each data analysis were identified, and the intersecting top 500 genes in each dataset were used for clustering and downstream analyses. Datasets underwent scaling based on nUMI and percent mitochondria gene content. The number of CCs (1:15) used to cluster cells was determined by manual inspection of scree plots. Further pathway analysis was performed using IPA.
Statistics and reproducibility
No statistical method was utilized to predetermine sample size. Student’s unpaired two-tailed t tests were performed using GraphPad Prism 8.4.3 software (GraphPad, La Jolla, CA) unless otherwise specified. Statistical significance is displayed as: N.S., not significant; *P < 0.05; **P < 0.01; ***P < 0.001.
Bulk RNA-seq (three biologically independent samples/group), scRNA-seq (single sample/group), and ChIP-seq (single sample/group) were performed one time. Immunofluorescence, bone marrow chimera, ChIP-qPCR and qRT-PCR experiments were performed twice independently with similar results. All other experiments were performed at least three times independently with similar results.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
All ChIP-seq, bulk RNA-seq, and scRNA-seq data reported here have been deposited in the Gene Expression Omnibus (GEO) under accession number SuperSeries GSE122533. The data of PPAR-γ microarray (GSE602497) had been previously disclosed in GEO by other researches. DAVID Bioinformatics Resources 6.860 and RPG: Ribosomal Protein Gene database70 are both publicly accessible. The data supporting this study are available in the Article, Supplementary Information, Source Data, or available from the authors upon reasonable requests. The reporting summary and editorial checklist for this article are available as a Supplementary file. Source data are provided with this paper.
Hussell, T. & Bell, T. J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81–93 (2014).
Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012).
Perdiguero, E. G. et al. The origin of tissue-resident macrophages: when an erythro-myeloid progenitor is an erythro-myeloid progenitor. Immunity 43, 1023–1024 (2015).
Hoeffel, G. et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42, 665–678 (2015).
Mass, E. et al. Specification of tissue-resident macrophages during organogenesis. Science 353, aaf4238 (2016).
Kopf, M., Schneider, C. & Nobs, S. P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36–44 (2015).
Schneider, C. et al. Induction of the nuclear receptor PPAR-gamma by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. Nat. Immunol. 15, 1026–1037 (2014).
Guilliams, M. et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210, 1977–1992 (2013).
Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792–804 (2013).
Machiels, B. et al. A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nat. Immunol. 18, 1310–1320 (2017).
Yu, X. et al. The cytokine TGF-beta promotes the development and homeostasis of alveolar macrophages. Immunity 47, 903–912 e904 (2017).
Amit, I., Winter, D. R. & Jung, S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat. Immunol. 17, 18–25 (2016).
Clark, M. D. et al. Structural insights into the assembly of the histone deacetylase-associated Sin3L/Rpd3L corepressor complex. Proc. Natl Acad. Sci. USA 112, E3669–3678 (2015).
Emmett, M. J. et al. Histone deacetylase 3 prepares brown adipose tissue for acute thermogenic challenge. Nature 546, 544–548 (2017).
Dovey, O. M., Foster, C. T. & Cowley, S. M. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 107, 8242–8247 (2010).
Guan, J. S. et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55–60 (2009).
Feng, D. et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315–1319 (2011).
Moser, M. A., Hagelkruys, A. & Seiser, C. Transcription and beyond: the role of mammalian class I lysine deacetylases. Chromosoma 123, 67–78 (2014).
Eckschlager, T., Plch, J., Stiborova, M. & Hrabeta, J. Histone deacetylase inhibitors as anticancer drugs. Int. J. Mol. Sci. 18, 1414 (2017).
Royce, S. G. & Karagiannis, T. C. Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions. Curr. Opin. Allergy Clin. Immunol. 14, 44–48 (2014).
van den Bosch, T., Kwiatkowski, M., Bischoff, R. & Dekker, F. J. Targeting transcription factor lysine acetylation in inflammatory airway diseases. Epigenomics 9, 1013–1028 (2017).
Chen, X. et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl Acad. Sci. USA 109, E2865–2874 (2012).
Mullican, S. E. et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 25, 2480–2488 (2011).
Gomez Perdiguero, E. et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547–551 (2015).
Yao, Y. et al. Micro RNAs are required for Langerhans cell, skin- and lung-resident macrophage ontogeny. J. Allergy Clin. Immunol. 142, 976–978 (2018).
Perdiguero, E. G. & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2–8 (2016).
Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat. Immunol. 20, 29–39 (2019).
MacParland, S. A. et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat. Commun. 9, 4383 (2018).
Yuan, Z. et al. Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival. J. Biol. Chem. 289, 15118–15129 (2014).
Yuan, Z. et al. TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine. Am. J. Physiol. Lung Cell Mol. Physiol. 310, L426–438 (2016).
Pagliari, L. J., Perlman, H., Liu, H. & Pope, R. M. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol. Cell Biol. 20, 8855–8865 (2000).
Hill, A. A. et al. Activation of NF-kappaB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment. Mol. Metab. 4, 665–677 (2015).
Liu, H. et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 102, 344–352 (2003).
Fletcher, J. S. et al. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. Oncogene 38, 2876–2884 (2019).
Summers, A. R. et al. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J. Clin. Invest. 123, 3112–3123 (2013).
Thapa, P., Romero Arocha, S., Chung, J. Y., Sant’Angelo, D. B. & Shapiro, V. S. Histone deacetylase 3 is required for iNKT cell development. Sci. Rep. 7, 5784 (2017).
Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).
Alenghat, T. et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 504, 153–157 (2013).
Remmerie, A. & Scott, C. L. Macrophages and lipid metabolism. Cell Immunol. 330, 27–42 (2018).
Vecchiarelli, A. et al. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 11, 130–137 (1994).
Blank, F. et al. Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes. Am. J. Respir. Cell Mol. Biol. 49, 67–77 (2013).
Briggs, J. A. et al. The dynamics of gene expression in vertebrate embryogenesis at single-cell resolution. Science 360, aar5780 (2018).
Wu, X. et al. Research techniques made simple: single-cell RNA sequencing and its applications in dermatology. J. Invest. Dermatol. 138, 1004–1009 (2018).
Loyher, P. L. et al. Macrophages of distinct origins contribute to tumor development in the lung. J. Exp. Med. 215, 2536–2553 (2018).
Schmitz, G., Langmann, T. & Heimerl, S. Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid Res. 42, 1513–1520 (2001).
Lam, B. K. & Austen, K. F. Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. Prostaglandins Other Lipid Mediat. 68-69, 511–520 (2002).
Weinberg, D. S. & Unanue, E. R. Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes. J. Immunol. 126, 794–799 (1981).
Angajala, A. et al. Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front. Immunol. 9, 1605 (2018).
Yao, Y. et al. CyTOF supports efficient detection of immune cell subsets from small samples. J. Immunol. Methods 415, 1–5 (2014).
Yoon, S. & Eom, G. H. HDAC and HDAC inhibitor: from cancer to cardiovascular diseases. Chonnam Med. J. 52, 1–11 (2016).
Suraweera, A., O’Byrne, K. J. & Richard, D. J. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front. Oncol. 8, 92 (2018).
Roche, J. & Bertrand, P. Inside HDACs with more selective HDAC inhibitors. Eur. J. Med. Chem. 121, 451–483 (2016).
Lavin, Y. et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169, 750–765 e717 (2017).
Knutson, S. K. et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27, 1017–1028 (2008).
Deng, L. et al. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am. J. Pathol. 176, 952–967 (2010).
Caton, M. L., Smith-Raska, M. R. & Reizis, B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204, 1653–1664 (2007).
Ruzankina, Y. et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1, 113–126 (2007).
He, W. et al. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl Acad. Sci. USA 100, 15712–15717 (2003).
Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
Kidder, B. L., Hu, G. & Zhao, K. ChIP-Seq: technical considerations for obtaining high-quality data. Nat. Immunol. 12, 918–922 (2011).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382–2383 (2015).
Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015).
Magella, B. et al. Cross-platform single cell analysis of kidney development shows stromal cells express Gdnf. Dev. Biol. 434, 36–47 (2018).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
Nakao, A., Yoshihama, M. & Kenmochi, N. RPG: the ribosomal protein gene database. Nucleic Acids Res. 32, D168–170 (2004).
We thank Dr. Hongmei Peng, Dr. Yu Wang, Dr. Jun Zhang, Dr. Xuan Wang, and Dr. Yi Yang for helping prepare samples. We thank Dr. Keji Zhao from the Lung and Blood Institute, National Institutes of Health, for valuable technical support in RNA-Seq. This study is partially supported by National Institutes of Health grants R01AR069681, R61AR076803, R01AI119041 (Q-S.M.), R01AR087659 (L.Z.), and the Henry Ford Immunology Program grants (T71016, Q-S.M.; T71017, L. Z.).
The authors declare no competing interests.
Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yao, Y., Liu, Q., Adrianto, I. et al. Histone deacetylase 3 controls lung alveolar macrophage development and homeostasis. Nat Commun 11, 3822 (2020). https://doi.org/10.1038/s41467-020-17630-6
Cell Proliferation (2021)